Exxon Mobil Just Raised Its Dividend for the 44th Year. Here Are 3 More Wall Street Favorites

Exxon Mobil (XOM) raised its dividend for the 44th year, increasing it by 4% to $1.07 per share. Chevron (CVX), AbbVie (ABBV), and ONEOK (OKE) also raised their dividends. All four companies reported strong free cash flow and analyst support. Exxon's dividend yield is 2.35%, Chevron's is 2.87%, AbbVie's is 2.28%, and ONEOK's is 4.46%.

Original reporting
Published Nov 4, 2026, 1:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 1:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Exxon Mobil Just Raised Its Dividend for the 44th Year. Here Are 3 More Wall Street Favorites — source image
Decision brief

The 30-second read

$XOMBullishMed
01

Why it matters

The fresh dividend announcements provide new data points for income‑oriented investors and may trigger short‑term buying pressure.

02

Market read

New dividend hikes across four large‑cap stocks may lift income‑focused segments of the market.

03

What to watch

Potential future cuts if oil prices stay low or if regulatory pressures increase on the energy sector.

Relevance 6/10Novelty 7/10Timing: today

Background

The article reviews four dividend‑heavy stocks that have just announced new quarterly payouts after the latest earnings season.

Company-level read

Ticker impact

$XOMBullishHigh confidence
Context

Exxon Mobil announced a 4% increase to its quarterly dividend to $1.07 per share, its 44th consecutive raise.

Expected impact

likely modest upside as yield improves and buybacks continue

Evidence & confidence

The raise is a fresh corporate action for a large-cap oil major with ample free cash flow.

$CVXBullishHigh confidence
Context

Chevron lifted its quarterly dividend to $1.78, continuing a streak of annual increases.

Expected impact

potential modest price support, especially in dividend‑focused portfolios

Evidence & confidence

The dividend hike is a new corporate action for a major energy company.

$ABBVBullishHigh confidence
Context

AbbVie raised its quarterly dividend by 5.2% to $1.82 per share.

Expected impact

likely slight upside as the higher yield attracts attention

Evidence & confidence

Fresh dividend raise for a large‑cap pharma firm, a material corporate action.

$OKEBullishHigh confidence
Context

ONEOK increased its quarterly dividend to $1.07, the highest yield among the list.

Expected impact

moderate upside as yield becomes more attractive

Evidence & confidence

New dividend increase for a mid‑cap midstream company, a clear corporate action.

Market effects

The dividend hikes reinforce the attractiveness of energy and pharma dividend stocks, potentially boosting sector inflows.

U.S. large‑cap dividend stocks may see modest buying pressure across major indices.

Higher U.S. dividend yields could influence global income‑focused funds and ETFs.

Counterpoint

Rising dividends may mask underlying exposure to volatile oil prices; investors could be overpaying for yield.

Key entities

  • Exxon Mobil

    Oil major with 44 consecutive dividend raises.

  • Chevron

    Oil major with rising dividend and recent EPS beat.

  • AbbVie

    Pharma company increasing dividend amid strong cash flow.

  • ONEOK

    Midstream firm with highest yield among the group.

Related articles

$ABBVLow

AbbVie (ABBV) Stock Climbs As Q3 Earnings Fuel Growth Case

AbbVie (ABBV) reported Q3 earnings, maintaining oncology revenue guidance of $6.6b for 2026, with Venclexta and Imbruvica contributing $3.1b and $2.1b respectively. The company is advancing new treatments, offsetting concerns about Imbruvica's performance. Analysts highlight potential undervaluation in three unspecified companies.

$TTELow

Africa’s LNG Exports Set to Soar 175% as Buyers Flee Hormuz

Africa's LNG exports are projected to grow 175% by 2034, reaching 98 bcm, driven by investments in Mozambique, Nigeria, Angola, Libya, and Ivory Coast. Mozambique's TotalEnergies (TTE) and Eni (E) projects, along with ExxonMobil's (XOM) Rovuma LNG, are key drivers. Nigeria's Train 7 expansion and Senegal-Mauritania's GTA project also contribute. TotalEnergies' Namibia projects and Tanzania's $42B LNG project, involving Equinor (EQNR) and Shell (SHEL), are notable.

$ABBVMed

Raleigh-Durham's Growth Story Is Moving Beyond Life Sciences

Raleigh-Durham's economy is diversifying beyond life sciences, attracting investments in tech, semiconductors, and advanced manufacturing. The region saw $4.4B in life sciences VC funding (2019-2024) and now has $140B in manufacturing investments. Companies like AbbVie ($1.4B) and Caterpillar ($1B) are expanding operations, driven by demand and workforce strengths.